Published

A 300 mg vial contains extractable zolbetuximab 300 mg, arginine 348.6 mg, sucrose 769.44 mg, polysorbate 80 3.15 mg, and phosphoric acid max. 179.1 mg

The maximum extractable amount of phosphoric acid per 300 mg vial is estimated to be 179.1 mg based on historical batch data for 100 mg/vial, corresponding to 3.8 mg/mL of phosphorus after reconstitution.1

Table 1. Composition of zolbetuximab 300 mg viala,1

Component

Extractable amountb

Theoretical unit amountc

Zolbetuximab

300 mg

315 mgd

Arginine

348.6 mg

366 mg

Phosphoric acid

sufficient quantity to pH 6.0e

sufficient quantity to pH 6.0e

Sucrose

769.44 mg

807.9 mg

Polysorbate 80

3.15 mg

3.3 mg

a Nitrogen gas is used for backfilling and is contained in the headspace of the zolbetuximab vial.

b Extractable amount refers to the quantity that a trained healthcare professional should be able to retrieve from the reconstituted solution when following the recommended reconstitution and extraction procedures.

c Theoretical unit amount refers to the quantity of zolbetuximab and excipients added to the vial to enable the extraction of 300 mg of zolbetuximab.

d Each vial contains an overfill of zolbetuximab relative to the nominal content (300 mg/vial) to ensure the deliverable dose is provided in each vial.

e The maximum extractable amount of phosphoric acid per 300 mg vial is estimated to be 179.1 mg based on historical batch data for 100 mg/vial, corresponding to 3.8 mg/mL of phosphorus after reconstitution. The upper limit for extractable phosphoric acid per vial based on safety data is 203.7 mg/vial (300 mg/vial).

  1. Data on File.

If you are not able to find the information through the Search function, please contact our Medical Communications and Engagement Department by using any of the channels below:

Connect with Field Medical

Connect with Field Medical

Medical Science Liaisons (MSLs) and Medical Value and Access (MV&A) team members are available to help answer your scientific and health economic questions.

 

Submit an Inquiry

Submit an Inquiry

For any medical inquiries, please submit your question online to Astellas Medical Information or call or fax your inquiry.

Astellas Phone: 1-800-727-7003

Fax: 1-877-829-7942

Hours: M–F, 8 AM–4:30 PM (CT)

Report an Adverse Event or Product Complaint

Report an Adverse Event or Product Complaint

Report adverse events and product complaints to Astellas or FDA MedWatch.

Astellas Phone: 1-800-727-7003

FDA MedWatch: 1-800-FDA-1088

Hours: M–F, 8 AM–4:30 PM (CT)